• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sana Biotechnology Inc (NQ: SANA )

    2.805 -0.085 (-2.94%)
    Streaming Delayed Price Updated: 9:55 AM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Sana Biotechnology Inc

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Sana Biotechnology Shares Are Rising Today
    Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S. 
    Via Benzinga
    Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
    Expect to disclose initial SC262 clinical data in 2024 
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at November and December 2023 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Sana Biotechnology to Present at September 2023 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
    Via Benzinga
    Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    3 Hidden Penny Stocks That Could Turn $100 into $10,000
    These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts. 
    Via InvestorPlace
    Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology to Present at June 2023 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. 
    Via Benzinga
    Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday
    U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
    Via Benzinga
    Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology Demonstrating its Hypoimmune-Engineered Cells Escape Immune Detection and Survive While Remaining Fully Functional
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    Sana Biotechnology Reports First Quarter 2023 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    7 High-Potential Penny Stocks in the Biotech Sector
    Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.